Nichd: r & d: bpca pediatric drug development clinical trial infrastructure: severable
Active Awarded Last action
- Contract number
- 75N94025F00002
- Awardee
-
Duke University UEI TP7EK8DZV6N5
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,996,766
Award facts
- Contract value 34% obligated
-
- $4,996,765.70 Current, with exercised options
- $14,810,162.00 Potential, with all options
- Completion date 22% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Durham, NC 27705, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $2,125,534 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $0 | |
| Original award | $2,871,232 |
About this award
The National Institute of Child Health and Human Development issued a delivery order to Duke University on September 20, 2025, with a ceiling value of $14.81 million for clinical trials infrastructure supporting pediatric drug development under the BPCA program, with ultimate completion by September 19, 2030.
This is Task Order 2 under Duke University's single-award Indefinite Delivery Contract with NIAID (titled "Evaluation and Testing Services for Vaccines and Other Biologics for Infectious Diseases - Task Areas A & C"), valued at $136.59 million through September 29, 2035. The parent IDC funds comprehensive support for pediatric drug development including establishment of expert teams, development of clinical protocols, conduct of pre-clinical studies, formulation development, and execution of Phases 1–3 pediatric clinical trials as part of the Pediatric Trials Network program.
Place of performance is Durham, North Carolina. The order is priced on a cost, no-fee basis with no set-aside. In FY2025, Duke self-performed all work with 0.2 FTEs of government-invoiced labor reported under Service Contract Inventory.
Quick answers
Who was awarded contract 75N94025F00002?
75N94025F00002 was awarded to Duke University by National Institute of Child Health and Human Development (National Institutes of Health) on September 20, 2025.
How much is contract 75N94025F00002 worth?
The government has obligated $4,996,766 on 75N94025F00002. Its potential value, with all options, is $14,810,162.
Is contract 75N94025F00002 an order under another contract?
Yes. 75N94025F00002 is a delivery order under 75N94025D00003, an indefinite delivery contract.
Was contract 75N94025F00002 competed?
The extent of competition for 75N94025F00002 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award